{'fraction_non_alphanumeric': 0.05025996533795494, 'fraction_numerical': 0.03119584055459272, 'mean_word_length': 5.21505376344086, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Capecitabine plus Cisplatin treatment for advanced gastric cancer in a patient with hepatic impairment secondary to metastases.

A 73-year-old female with advanced gastric cancer (AGC) wasreferred to our hospital. She had visited a clinic with complaints ofpassing brown urine for 2 weeks. Her blood test showed hyperbil-irubinemia with 10.7 mg/dL of serum total bilirubin and 8.4 mg/dLof direct bilirubin, and liver and biliary enzymes including aspartateaminotransferase (AST; 389 IU/mL), alanine aminotransferase(ALT; 504 IU/mL), alkaline phosphatase (ALP; 3,256 IU/mL), and